Physician profile
Boris Epstein
NPI 1194718130
$7,388.96
in general payments reported to CMS, 2019-2025
23 companies · $1,645 in 2025
The $1,645 reported for 2025 was more than what 91% of Adult Medicine providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $423 · 2021: $1,330 · 2022: $1,646 · 2023: $1,105 · 2024: $1,036 · 2025: $1,645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,786.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,786.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,770.55 | 2023-2025 | Caplyta |
| Sunovion Pharmaceuticals INC. | $1,621.83 | 2021-2022 | |
| Incyte Corporation | $957.69 | 2021-2025 | Opzelura |
| Abbvie INC. | $808.51 | 2020-2025 | |
| Amgen INC. | $471.82 | 2020-2025 | Repatha, Otezla, Repatha |
| Pfizer INC. | $332.25 | 2019-2025 | |
| Aimmune Therapeutics, INC. | $188.21 | 2024-2025 | Zenpep |
| Novo Nordisk INC | $177.88 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Nestle Healthcare Nutrition INC. | $168.43 | 2020-2023 | |
| Allergan, INC. | $148.50 | 2020 | |
| Amarin Pharma, INC. | $148.27 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $86.61 | 2022 | |
| Zimmer Biomet Holdings, INC. | $86.42 | 2023 | Comprehensive |
| Otsuka America Pharmaceutical, INC. | $77.28 | 2024 | Rexulti |
| Celgene Corporation | $69.62 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $61.52 | 2024-2025 | Contrave |
| Lilly USA, LLC | $46.45 | 2025 | Zepbound, Mounjaro |
| Exact Sciences Corporation | $40.89 | 2023 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $34.34 | 2023-2025 | Symbravo, Sunosi |
| Indivior INC. | $30.55 | 2019 | |
| Scilex Pharmaceuticals INC. | $23.21 | 2020 | |
| Ardelyx, INC. | $22.57 | 2025 | Ibsrela |
| Intra-Sana Laboratories | $15.56 | 2023 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boris Epstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.